These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23540872)

  • 1. Chronic obstructive pulmonary disease is just one component of the complex multimorbidities in patients with COPD.
    Clini EM; Beghé B; Fabbri LM
    Am J Respir Crit Care Med; 2013 Apr; 187(7):668-71. PubMed ID: 23540872
    [No Abstract]   [Full Text] [Related]  

  • 2. Objectively identified comorbidities in COPD: impact on pulmonary rehabilitation outcomes.
    Mesquita R; Vanfleteren LE; Franssen FM; Sarv J; Taib Z; Groenen MT; Gaffron S; Bruijnzeel PL; Pitta F; Wouters EF; Spruit MA
    Eur Respir J; 2015 Aug; 46(2):545-8. PubMed ID: 26113670
    [No Abstract]   [Full Text] [Related]  

  • 3. Clusters of comorbidities based on validated objective measurements and systemic inflammation in patients with chronic obstructive pulmonary disease.
    Vanfleteren LE; Spruit MA; Groenen M; Gaffron S; van Empel VP; Bruijnzeel PL; Rutten EP; Op 't Roodt J; Wouters EF; Franssen FM
    Am J Respir Crit Care Med; 2013 Apr; 187(7):728-35. PubMed ID: 23392440
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Comorbidities on the Treatment of Chronic Obstructive Pulmonary Disease.
    Garvey C; Criner GJ
    Am J Med; 2018 Sep; 131(9S):23-29. PubMed ID: 29777661
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Systemic consequences of COPD.
    Tkác J; Man SF; Sin DD
    Ther Adv Respir Dis; 2007 Oct; 1(1):47-59. PubMed ID: 19124347
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Managing comorbidities in COPD.
    Hillas G; Perlikos F; Tsiligianni I; Tzanakis N
    Int J Chron Obstruct Pulmon Dis; 2015; 10():95-109. PubMed ID: 25609943
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Chronic obstructive pulmonary disease and associated illnesses].
    Chuchalin AG
    Ter Arkh; 2008; 80(8):45-50. PubMed ID: 18807540
    [No Abstract]   [Full Text] [Related]  

  • 8. COPD as a lung disease with systemic consequences--clinical impact, mechanisms, and potential for early intervention.
    Decramer M; Rennard S; Troosters T; Mapel DW; Giardino N; Mannino D; Wouters E; Sethi S; Cooper CB
    COPD; 2008 Aug; 5(4):235-56. PubMed ID: 18671149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comorbidities in Patients With Chronic Obstructive Pulmonary Disease and Pulmonary Rehabilitation Outcomes.
    Tunsupon P; Lal A; Abo Khamis M; Mador MJ
    J Cardiopulm Rehabil Prev; 2017 Jul; 37(4):283-289. PubMed ID: 28410285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Cachexia in chronic pulmonary obstructive disease].
    Chwist-Nowak A; Rozentryt P; Chwist J; Jarzab J
    Wiad Lek; 2006; 59(1-2):84-8. PubMed ID: 16646299
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Pathomechanism of cachexia in chronic obstructive pulmonary disease].
    Jarzab J; Chwist-Nowak A; Rozentryt P; Chwist J
    Wiad Lek; 2005; 58(11-12):647-51. PubMed ID: 16594476
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adiponectin: an attractive marker for metabolic disorders in Chronic Obstructive Pulmonary Disease (COPD).
    Bianco A; Mazzarella G; Turchiarelli V; Nigro E; Corbi G; Scudiero O; Sofia M; Daniele A
    Nutrients; 2013 Oct; 5(10):4115-25. PubMed ID: 24128974
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comorbidity in chronic obstructive pulmonary disease.
    Negewo NA; McDonald VM; Gibson PG
    Respir Investig; 2015 Nov; 53(6):249-58. PubMed ID: 26521102
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence and burden of comorbidities in Chronic Obstructive Pulmonary Disease.
    Corlateanu A; Covantev S; Mathioudakis AG; Botnaru V; Siafakas N
    Respir Investig; 2016 Nov; 54(6):387-396. PubMed ID: 27886849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Chronic obstructive pulmonary disease and cardiovascular diseases].
    Passowicz-Muszyńska E; Gostkowska-Malec A; Jankowska R; Piesiak P
    Pneumonol Alergol Pol; 2010; 78(1):28-32. PubMed ID: 20162516
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimorbidity and COPD Medication Receipt Among Medicaid Beneficiaries With Newly Diagnosed COPD.
    Ajmera M; Sambamoorthi U; Metzger A; Dwibedi N; Rust G; Tworek C
    Respir Care; 2015 Nov; 60(11):1592-602. PubMed ID: 26329356
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Strategies for reducing the risk of cardiovascular disease in patients with chronic obstructive pulmonary disease.
    Ferri C
    High Blood Press Cardiovasc Prev; 2015 Jun; 22(2):103-11. PubMed ID: 25655487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular dysfunction in chronic obstructive pulmonary disease: current evidence and perspectives.
    Clarenbach CF; Thurnheer R; Kohler M
    Expert Rev Respir Med; 2012 Feb; 6(1):37-43. PubMed ID: 22283577
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overlooking cardiovascular risk in patients with COPD.
    Turner RD; Gwavava CM; Bianchi SM
    Chest; 2011 Nov; 140(5):1385-1386. PubMed ID: 22045886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.